These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27544302)

  • 1. Management of non-clear cell renal cell carcinoma: Current approaches.
    Tsimafeyeu I
    Urol Oncol; 2017 Jan; 35(1):5-13. PubMed ID: 27544302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic renal cell carcinoma: current standards of care.
    Thompson JA
    Clin J Oncol Nurs; 2009 Dec; 13 Suppl():8-12. PubMed ID: 19948454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapy for Metastatic Renal Cell Carcinoma.
    Afriansyah A; Hamid AR; Mochtar CA; Umbas R
    Acta Med Indones; 2016 Oct; 48(4):335-347. PubMed ID: 28143997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present state of target therapy for disseminated renal cell carcinoma.
    Waalkes S; Kramer M; Herrmann TR; Schrader AJ; Kuczyk MA; Merseburger AS
    Immunotherapy; 2010 May; 2(3):393-8. PubMed ID: 20635903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the Management of Rare Kidney Cancers.
    Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
    Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of metastatic renal cell carcinoma].
    Thuret R; Maurin C; Sun M; Perrotte P; Karakiewicz PI
    Prog Urol; 2011 Apr; 21(4):233-44. PubMed ID: 21482396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of locally advanced renal tumors].
    Sánchez Zalabardo D; Millán Serrano JA; De Pablo Cárdenas A; Cuesta Alcalá JA
    Actas Urol Esp; 2010 Feb; 34(2):134-41. PubMed ID: 20403277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temsirolimus (Torisel) for advanced renal cell carcinoma.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):103-4. PubMed ID: 18084154
    [No Abstract]   [Full Text] [Related]  

  • 9. Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis.
    Guida A; Masini C; Milella M; Di Lorenzo G; Santoni M; Prati V; Porta C; Cosmai L; Donati D; del Giovane C; Mighali P; Sabbatini R
    Future Oncol; 2015; 11(23):3159-66. PubMed ID: 26544922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association.
    Kanayama HO; Fukumori T; Fujimoto H; Nakanishi H; Ohyama C; Suzuki K; Nishiyama H; Eto M; Miki T; Kamoi K; Kubota Y; Takahashi S; Homma Y; Naito S
    Int J Urol; 2015 Sep; 22(9):S1-7. PubMed ID: 26332059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: the translation of molecular biology into new treatments, new patient outcomes, and nursing implications.
    Moldawer NP; Figlin R
    Oncol Nurs Forum; 2008 Jul; 35(4):699-708. PubMed ID: 18591174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapy in renal cell carcinoma: where do we go from here?
    Rini BI
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1753-60. PubMed ID: 17181489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing response to subsequent treatment lines with tyrosine kinase inhibitors in an adolescent with metastatic renal cell carcinoma.
    De Pasquale MD; Pessolano R; Boldrini R; Ilari I; Donfrancesco A; Cortesi E; Jenkner A
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):e176-9. PubMed ID: 21552143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of complete response to everolimus for metastatic renal cell carcinoma.
    Iwasaki K; Obara W; Fujioka T
    Int J Urol; 2012 Sep; 19(9):891-2. PubMed ID: 22624586
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.
    Pouessel D; Culine S
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1761-7. PubMed ID: 17181490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinoma.
    Rodríguez Faba O; Breda A; Rosales A; Palou J; Algaba F; Maroto Rey P; Villavicencio H
    Eur Urol; 2010 Aug; 58(2):307-10. PubMed ID: 20347211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
    Miller K; Bergmann L; Jäger E; Jakse G; Wirth M; Keilholz U;
    Aktuelle Urol; 2009 Jan; 40(1):27-30. PubMed ID: 19177318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies.
    Patel SB; Stenehjem DD; Gill DM; Tantravahi SK; Agarwal AM; Hsu J; Vuong W; Pal SK; Agarwal N
    Clin Genitourin Cancer; 2016 Apr; 14(2):153-9. PubMed ID: 26781820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling inhibitors in metastatic renal cell carcinoma.
    Escudier B
    Cancer J; 2008; 14(5):325-9. PubMed ID: 18836338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of renal cell carcinoma].
    Guy L; Bay JO; Bastide C; Mahammedi H; Bruyere F; Karsenty G
    Prog Urol; 2013 Nov; 23(15):1225-37. PubMed ID: 24183081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.